Post discharge day 1 Post discharge day 2 Post discharge day 3
Group I Group II Group I Group II Group I Group II
Oral opioid intake 5.0 ± 3.6 6.0 ± 3.5 1.9 ± 2.5 3.2 ± 3.3 0.8 ± 1.7 1.3 ± 2.2
Nausea incidence 20 (54) 18 (46) 6 (16) 7 (18) 4 (11) 4 (10)
p-value -- 0.49a -- 0.84a -- 0.94a
  -- -- -- -- -- 0.67b
Nausea severity N=37   N=39  N=37  N=39 N=37   N=39
No nausea 17 (45.9%) 21 (53.8%) 31 (83.8) 32 (82.1) 33 (89.2) 35 (89.7)
Mild nausea 8 (21.6) 9 (23.1) 4 (10.8) 4 (10.3) 2 (5.4) 2 (5.1)
Moderate nausea 7 (18.9) 5 (12.8) 1 (2.7) 1 (2.6) 2 (5.4) 0 (0)
Severe nausea 5 (13.5) 4 (10.3) 1 (2.7) 2 (5.1) 0 (0) 2 (5.1)
p-value -- 0.83c -- 1.00c -- 1.00c
NRS1 pain at rest 3.2 ± 2.0 2.8 ± 2.4 2.5 ± 1.8 1.8 ± 1.8 2.0 ± 1.8 1.7 ± 1.7
NRS1 pain with movement 5.8 ± 1.9 5.3 ± 2.7 4.3 ± 2.0 3.9 ± 2.2 4.0 ± 2.0 3.2 ± 2.2
aPearson's Chi Square test.
bAnalysis of General Estimating Equation parameter estimates.
cFisher's exact test.
1NRS = Numeric Rating Scale.
Table 3: Opioid intake, nausea and patient-reported pain scores.